General Information of the Cell Line
Cell Line ID
CL000186
Cell Line Name
RPMI-8226
Synonyms
RPMI 8226
RPMI.8226
RPMI8226
RPMI no. 8226
RPMI no 8226
RPMI #8226
8226
RPMI 8226/S
RPMI-8226S
RPMI8226/S
8226/S
Roswell Park Memorial Institute 8226
GM02132
GM2132
GM 2132
GM02132C
Simpson
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0014
Tissue Information
Peripheral blood
Disease
Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT06430, DEP domain-containing mTOR-interacting protein
Compound ID Compound Name Compound Formula
CP0855455
N'-(Perchlorocyclopenta-2,4-dien-1-yli-dene)benzohydrazide
   Show/Hide
C12H6Cl4N2O
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0883965
1-(3-Fluorophenyl)-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C11H5Cl4FN2
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0904881
1-(Perchlorocyclopenta-2,4-dien-1-ylidene)-2-phenylhydrazine
   Show/Hide
C11H6Cl4N2
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0867599
N-Benzoyl-N'-(perchlorocyclopenta-2,4-dien-1-ylidene)benzohydrazide
   Show/Hide
C19H10Cl4N2O2
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0909765
1-(3,5-dichlorophenyl)-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C11H4Cl6N2
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0389218
(2,3,4,5-tetrachlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C5H2Cl4N2
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0930486
1,1-Dimethyl-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C7H6Cl4N2
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0862692
1-(tert-Butyl)-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C9H10Cl4N2
 1
1
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CP0903507
1-Cyclohexyl-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C11H12Cl4N2
 1
1
IC50 > 5000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3  1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0004475
RICOLINOSTAT
   Show/Hide
C24H27N5O3  1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0007711
(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-N'-propylprop-2-enehydrazide;2,2,2-trifluoroacetic acid
   Show/Hide
C26H31F3N4O3  1
1
LC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0008108
(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol
   Show/Hide
C17H18N4O4  1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0014330
N-(1-tert-butyl-3-phenylpyrazolo[3,4-d]pyrimidin-4-yl)prop-2-enamide
   Show/Hide
C18H19N5O  1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0023952
8-[6-(2-methoxyethylcarbamoyl)pyridin-3-yl]oxy-4,5-dihydrothieno[3,4-g][1,2]benzothiazole-6-carboxamide
   Show/Hide
C19H18N4O4S2  1
1
GI50 = 2.5 nM
   TI
   LI
   LO
   TS
CP0029803
N-[3-[2-(3-amino-1H-indazol-4-yl)ethynyl]phenyl]-4-morpholin-4-yl-3-(trifluoromethyl)benzamide
   Show/Hide
C27H22F3N5O2  1
1
GI50 = 1980 nM
   TI
   LI
   LO
   TS
CP0030986
N-(4-(2-propylhydrazine-1- carbonyl)benzyl)cinnamamide
   Show/Hide
C20H23N3O2  1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0036114
(18Z)-12-methoxy-18-({3-[(1E)-1-(methoxyimino)ethyl]thiophen-2-yl}methylidene)-3,5,5-trimethyl-17-oxa-6-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1(10),2(7),3,8,11,13,15-heptaen-13-ol
   Show/Hide
C28H28N2O4S  1
1
IC50 = 9.5 nM
   TI
   LI
   LO
   TS
CP0058714
1-[2-[4-[1-[4-[2-(azepan-1-yl)ethoxy]phenyl]-2-phenylbut-1-enyl]phenoxy]ethyl]azepane
   Show/Hide
C38H50N2O2  1
1
CC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0075396
N-[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-2-oxoethyl]-3-[1,1-bis[4-[2-(azepan-1-yl)ethoxy]phenyl]but-1-en-2-yl]benzamide
   Show/Hide
C89H150N36O12  1
1
CC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0118041
US10214477, Example 5
   Show/Hide
C15H22N2  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0213128
(18Z)-12-methoxy-18-{[3-(methoxymethyl)thiophen-2-yl]methylidene}-3,5,5-trimethyl-17-oxa-6-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1(10),2(7),3,8,11,13,15-heptaen-13-ol
   Show/Hide
C27H27NO4S  1
1
IC50 = 8.5 nM
   TI
   LI
   LO
   TS
CP0319200
1,3-dihydroisoindol-2-yl-[2,4-dihydroxy-5-[(4-methylphenyl)methyl]phenyl]methanone
   Show/Hide
C23H21NO3  1
1
GI50 = 2700 nM
   TI
   LI
   LO
   TS
CP0366755
(5-benzyl-2,4-dihydroxyphenyl)-(1,3-dihydroisoindol-2-yl)methanone
   Show/Hide
C22H19NO3  1
1
GI50 = 3700 nM
   TI
   LI
   LO
   TS
CP0370065
5-(4-chlorophenyl)-2-(4-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
C17H12ClN3OS  1
1
LC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0380500
(E)-N-hydroxy-3-[4-[[[1-(4-methylanilino)isoquinolin-7-yl]amino]methyl]phenyl]prop-2-enamide
   Show/Hide
C26H24N4O2  1
1
IC50 = 2040 nM
   TI
   LI
   LO
   TS
CP0397887
N-[4-(3-cyanoanilino)thieno[3,2-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide
   Show/Hide
C21H22N6O3S  1
1
IC50 = 1580 nM
   TI
   LI
   LO
   TS
CP0416995
N-[4-(2,4-difluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide
   Show/Hide
C20H21F2N5O3S  1
1
IC50 = 1740 nM
   TI
   LI
   LO
   TS
CP0428528
N'-hydroxy-N-(1-morpholin-4-ylisoquinolin-7-yl)octanediamide
   Show/Hide
C21H28N4O4  1
1
IC50 = 1330 nM
   TI
   LI
   LO
   TS
CP0429043
N-[1-(2-fluoro-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide
   Show/Hide
C24H27FN4O3  1
1
IC50 = 2040 nM
   TI
   LI
   LO
   TS
CP0431455
N-[2-[2-(diethylamino)ethyl]-1-oxoisoquinolin-7-yl]-N'-hydroxyoctanediamide
   Show/Hide
C23H34N4O4  1
1
IC50 = 2160 nM
   TI
   LI
   LO
   TS
CP0441071
4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[7-(hydroxyamino)-7-oxoheptyl]amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
   Show/Hide
C46H53ClN8O8S  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0441206
N-[4-(4-fluoro-2-methylanilino)thieno[3,2-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide
   Show/Hide
C21H24FN5O3S  1
1
IC50 = 1950 nM
   TI
   LI
   LO
   TS
CP0443042
N-[1-(2-fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide
   Show/Hide
C23H25FN4O3  1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0447287
N'-hydroxy-N-[4-(3-methoxyanilino)thieno[3,2-d]pyrimidin-6-yl]octanediamide
   Show/Hide
C21H25N5O4S  1
1
IC50 = 1260 nM
   TI
   LI
   LO
   TS
CP0452639
N-(2-butyl-1-oxoisoquinolin-7-yl)-N'-hydroxyoctanediamide
   Show/Hide
C21H29N3O4  1
1
IC50 = 1880 nM
   TI
   LI
   LO
   TS
CP0454504
N-[4-(2-fluoro-5-methylanilino)thieno[3,2-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide
   Show/Hide
C21H24FN5O3S  1
1
IC50 = 1060 nM
   TI
   LI
   LO
   TS
CP0454529
N-[4-(3-tert-butylanilino)thieno[3,2-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide
   Show/Hide
C24H31N5O3S  1
1
IC50 = 3550 nM
   TI
   LI
   LO
   TS
CP0457975
2-{[(18Z)-13-hydroxy-12-methoxy-3,5,5-trimethyl-17-oxa-6-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1(10),2(7),3,8,11,13,15-heptaen-18-ylidene]methyl}thiophene-3-carbonitrile
   Show/Hide
C26H22N2O3S  1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0463168
(18Z)-12-methoxy-3,5,5-trimethyl-18-{[3-(piperidin-1-ylcarbonyl)thiophen-2-yl]methylidene}-17-oxa-6-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1(10),2(7),3,8,11,13,15-heptaen-13-ol
   Show/Hide
C31H32N2O4S  1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0465729
N'-hydroxy-N-[4-(3-propan-2-ylanilino)thieno[3,2-d]pyrimidin-6-yl]octanediamide
   Show/Hide
C23H29N5O3S  1
1
IC50 = 2080 nM
   TI
   LI
   LO
   TS
CP0484576
N'-hydroxy-N-[2-(3-methylbutyl)-1-oxoisoquinolin-7-yl]octanediamide
   Show/Hide
C22H31N3O4  1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0540865
5-[[4-(methylamino)-5-(1-methylpyrazol-4-yl)pyrimidin-2-yl]amino]-3-[(3R)-piperidin-3-yl]oxypyridine-2-carbonitrile
   Show/Hide
C20H23N9O  1
1
IC50 = 1991 nM
   TI
   LI
   LO
   TS
CP0855455
N'-(Perchlorocyclopenta-2,4-dien-1-yli-dene)benzohydrazide
   Show/Hide
C12H6Cl4N2O  1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0888197
(Z)-5-(2'-(3'-acetylthienylmethylidene))1,2-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5H-chromeno[3,4-f]quinoline
   Show/Hide
C27H25NO4S  1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0903507
1-Cyclohexyl-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C11H12Cl4N2  1
1
IC50 > 3000 nM
   TI
   LI
   LO
   TS
CP0904881
1-(Perchlorocyclopenta-2,4-dien-1-ylidene)-2-phenylhydrazine
   Show/Hide
C11H6Cl4N2  1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0906523
7-Benzyl-N-(4-methoxyphenyl)-N,2,5-trimethyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine hydrochloride
   Show/Hide
C23H25ClN4O  1
1
GI50 = 36.9 nM
   TI
   LI
   LO
   TS
CP0909765
1-(3,5-dichlorophenyl)-2-(perchlorocyclopenta-2,4-dien-1-ylidene)hydrazine
   Show/Hide
C11H4Cl6N2  1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6 Homo sapiens (Human) Adult acute monocytic leukemia
HL-60 Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-13 Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2 Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14 Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1 Homo sapiens (Human) Childhood acute monocytic leukemia
MV4-11 Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue Homo sapiens (Human) Childhood acute monocytic leukemia
SEM Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
Jurkat E6.1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-CEM Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
EoL-1 Homo sapiens (Human) Chronic eosinophilic leukemia, not otherwise specified
CII Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL Homo sapiens (Human) Erythroleukemia
UKE-1 Homo sapiens (Human) Essential thrombocythemia
L-1236 Homo sapiens (Human) Hodgkin lymphoma
Granta-519 Homo sapiens (Human) Mantle cell lymphoma
JeKo-1 Homo sapiens (Human) Mantle cell lymphoma
Mino Homo sapiens (Human) Mantle cell lymphoma
HMC-1 Homo sapiens (Human) Mast cell leukemia
NK-92 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
OPM-2 Homo sapiens (Human) Plasma cell myeloma
U266B1 Homo sapiens (Human) Plasma cell myeloma
KMS-18 Homo sapiens (Human) Plasma cell myeloma
MM1.S Homo sapiens (Human) Plasma cell myeloma
MM1.R Homo sapiens (Human) Plasma cell myeloma
OPM-1 Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40 Homo sapiens (Human) Plasma cell myeloma
HuT 78 Homo sapiens (Human) Sezary syndrome
H9 Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1 Homo sapiens (Human) Sickle cell disease
RBL-1 Rattus norvegicus (Rat) Rat leukemia
RBL-2H3 Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28 Homo sapiens (Human) -
JY Homo sapiens (Human) -
C.M.L. Homo sapiens (Human) -
BON Homo sapiens (Human) -
PBMC iPSC #1 Homo sapiens (Human) -
LCL 721 Homo sapiens (Human) -